Notice of Changes in Board Members and Personnel of the Company and Its Consolidated Subsidiary

To Whom It May Concern:

May 13, 2015

Company Name: Taisho Pharmaceutical Holdings Co., Ltd. Head Office: 3-24-1, Takada, Toshima-ku, Tokyo Representative: Akira Uehara, President and CEO

(First Section of TSE: Code 4581) Contact: Makoto Funahashi, General Manager

Corporate Communications

(Tel: +81-3-3985-1115)

Notice of Changes in Board Members and Personnel of the Company and Its Consolidated Subsidiary

Taisho Pharmaceutical Holdings Co., Ltd. ("the Company") and its consolidated subsidiary Taisho Pharmaceutical Co., Ltd. ("Taisho Pharmaceutical") [Head Office: Toshima-ku, Tokyo, President: Shigeru Uehara] have announced that the two companies decided at
meetings of their respective Board of Directors held today to informally approve the following changes in Representative Directors, Directors and Audit & Supervisory Board Members.
1. Taisho Pharmaceutical Holdings Co., Ltd.
The following changes in Board members are scheduled to be officially approved at the 4th Ordinary General Meeting of Shareholders to be held on June 26, 2015 and the subsequent Board of Directors' meeting to be held on the same day.
(1) Change in Representative Director (As of June 26, 2015)
Corporate Adviser Hisataka Hotta (Currently Senior Vice President and
Representative Director)
(2) Changes in Directors (As of June 26, 2015)
Executive Vice President Shigeru Uehara (Currently Director)
Corporate Adviser and Director
Akira Ohira (Currently Director)
Director Kazuya Kameo (Currently Executive Officer) Director Tetsu Watanabe (Currently Executive Officer) Director(Outside) Hiroyuki Uemura (Currently Audit & Supervisory
Board Member (Outside))
To resign Kiyomi Chuurei
To resign Jun-ichi Fukudome
(3) Changes in Audit & Supervisory Board Members (As of June 26, 2015)
Audit & Supervisory Board
Member
Audit & Supervisory Board
Member (Outside)
Audit & Supervisory Board
Member (Outside)
Yoshiaki Sasaki (Currently Director, Taisho Toyama
Pharmaceutical Co., Ltd.) Chushiro Aoi (Currently President and
Representative Director, A-TOM Co., Ltd.)
Junya Sato (Currently Lawyer, Legal Advisor for
the Company)
To resign Shigeo Morimoto
To resign(Outside) Isao Yoshikawa
2. Taisho Pharmaceutical Co., Ltd.
The following changes in Board members are scheduled to be officially approved at the 106th Ordinary General Meeting of Shareholders to be held on June 26, 2015 and the subsequent Board of Directors' meeting to be held on the same day.
(1) Changes in Representative Directors (As of June 26, 2015)
Chairman and Director Akira Uehara (Currently Chairman and
Representative Director)
Corporate Adviser and
Director
Hisataka Hotta (Currently Vice Chairman and
Representative Director)
(2) Changes in Directors (As of June 26, 2015)
Audit & Supervisory Board
Member
Kazuya Kameo (Currently Executive Officer)
Director Tetsu Watanabe (Currently Senior Executive Officer) Director Itsumi Takahashi (Currently Senior Executive Officer) To resign Kiyomi Chuurei
To resign Jun-ichi Fukudome
(3) Changes in Audit & Supervisory Board Members (As of June 26, 2015)
Audit & Supervisory Board
Member
Yoshiaki Sasaki (Currently Director, Taisho Toyama
Pharmaceutical Co., Ltd.)
To resign Shigeo Morimoto

distributed by